Table I.
Reported use of factor concentrates in Canada from 2007 to 2012.
| 2012–2013 | 2011–2012 | 2010–2011 | 2009–2010 | 2008–2009 | 2007–2008 | ||
|---|---|---|---|---|---|---|---|
|
|
|||||||
| Product | Unit | Quantity | Quantity | Quantity | Quantity | Quantity | Quantity |
| Factor Eight Inhibitor Bypassing Activity | IU | 14.059.865 | 14.059.865 | 12.139.931 | 11.406.109 | 9.492.307 | 7.096.409 |
| Compl.prot.total Octaplex | IU | 3.360.500 | 3.360.500 | 9.942.500 | 920.000 | 12.600 | 0 |
| Factor IX | IU | 42.975.510 | 42.975.510 | 43.612.325 | 39.861.108 | 37.136.322 | 33.569.155 |
| Factor VIIa | IU | 1.463.400 | 1.463.400 | 1.248.000 | 1.107.000 | 1.227.000 | 978.600 |
| Factor VIIa rec. NiaStase® | mg | 25.483 | 25.483 | 30.502 | 30.686 | 34.124 | 33.740 |
| Porcine FVIII | IU | - | - | 0 | 0 | 0 | 249.340 |
| Recombinant Factor VIII | IU | 178.234.199 | 178.234.199 | 178.792.631 | 164.791.696 | 155.487.497 | 144.129.307 |
| Factor VIII/VWF | IU | 28.730.716 | 28.730.716 | 26.711.363 | 24.364.514 | 20.701.440 | 18.620.052 |
| Factor XI | IU | 35.890 | 35.890 | 51.275 | 74.455 | 64.575 | 85.705 |
| Factor XIII | IU | 559.000 | 559.000 | 533.000 | 471.750 | 522.000 | 444.250 |
| Fibrinogen | g | 542 | 542 | 933 | 390 | 1.188 | 901 |